Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Consensus Rating of "Moderate Buy" from Brokerages

Key Points

• Aveanna Healthcare (NASDAQ:AVAH) has a consensus rating of Moderate Buy from 11 brokerages—six hold, four buy and one strong buy—with an average 1‑year price target of $10.25.
• Company insiders have sold 738,957 shares valued at about $5.46 million over the last 90 days (including CFO Matthew Buckhalter and Patrick Cunningham), leaving insiders with a 7% ownership stake.
• AVAH opened at $6.75, trades in a 1‑year range of $3.73–$10.32, has a market capitalization of $1.47 billion and a PE ratio of 6.62, but carries a high debt‑to‑equity ratio of 6.62.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) has been given a consensus rating of "Moderate Buy" by the eleven brokerages that are covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $10.25.

AVAH has been the topic of several recent research reports. Raymond James Financial raised shares of Aveanna Healthcare from an "outperform" rating to a "strong-buy" rating and set a $13.00 price target on the stock in a research report on Friday, March 20th. Zacks Research cut shares of Aveanna Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, February 3rd. Barclays decreased their price target on shares of Aveanna Healthcare from $11.00 to $9.50 and set an "overweight" rating for the company in a research note on Wednesday, March 25th. Truist Financial reduced their price objective on shares of Aveanna Healthcare from $9.00 to $8.00 and set a "hold" rating for the company in a research note on Monday, April 13th. Finally, UBS Group lifted their price objective on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a "neutral" rating in a research note on Thursday, January 15th.

Insider Activity

In other news, CFO Matthew Buckhalter sold 13,512 shares of the business's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $97,421.52. Following the completion of the transaction, the chief financial officer directly owned 529,243 shares in the company, valued at $3,815,842.03. The trade was a 2.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Patrick A. Cunningham sold 18,436 shares of the business's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $132,923.56. Following the transaction, the insider owned 337,755 shares of the company's stock, valued at $2,435,213.55. This trade represents a 5.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 738,957 shares of company stock valued at $5,458,175 over the last 90 days. Company insiders own 7.00% of the company's stock.

Institutional Trading of Aveanna Healthcare

A number of hedge funds have recently made changes to their positions in AVAH. Caitong International Asset Management Co. Ltd lifted its stake in Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company's stock worth $27,000 after purchasing an additional 2,400 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Aveanna Healthcare in the second quarter valued at about $43,000. Lion Street Advisors LLC purchased a new position in shares of Aveanna Healthcare in the third quarter valued at about $89,000. EverSource Wealth Advisors LLC increased its position in shares of Aveanna Healthcare by 88,100.0% in the third quarter. EverSource Wealth Advisors LLC now owns 11,466 shares of the company's stock valued at $102,000 after acquiring an additional 11,453 shares during the period. Finally, State of Alaska Department of Revenue purchased a new position in shares of Aveanna Healthcare during the third quarter valued at about $106,000. 87.96% of the stock is owned by institutional investors.

Aveanna Healthcare Price Performance

AVAH stock opened at $6.75 on Tuesday. Aveanna Healthcare has a 1 year low of $3.73 and a 1 year high of $10.32. The stock has a market capitalization of $1.47 billion, a PE ratio of 6.62 and a beta of 2.08. The company has a debt-to-equity ratio of 6.62, a current ratio of 1.32 and a quick ratio of 1.32. The company's 50-day moving average is $6.83 and its 200-day moving average is $8.14.

About Aveanna Healthcare

Aveanna Healthcare, Inc NASDAQ: AVAH is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna's offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.